Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001042392 | SCV001206070 | uncertain significance | Charcot-Marie-Tooth disease type 2 | 2023-10-15 | criteria provided, single submitter | clinical testing | This sequence change affects codon 635 of the GARS mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the GARS protein. This variant is present in population databases (rs773889809, gnomAD 0.009%). This variant has not been reported in the literature in individuals affected with GARS-related conditions. ClinVar contains an entry for this variant (Variation ID: 694995). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Athena Diagnostics | RCV003482321 | SCV004229653 | uncertain significance | not provided | 2023-08-18 | criteria provided, single submitter | clinical testing | Available data are insufficient to determine the clinical significance of the variant at this time. The frequency of this variant in the general population is higher than would generally be expected for pathogenic variants in this gene (http://gnomad.broadinstitute.org). Computational tools yielded inconclusive predictions regarding the effect of this variant on RNA splicing. |
Gene |
RCV003482321 | SCV005331865 | uncertain significance | not provided | 2023-08-18 | criteria provided, single submitter | clinical testing | In silico analysis supports a deleterious effect on splicing; Has not been previously published as pathogenic or benign to our knowledge |
Genesis Genome Database | RCV000857182 | SCV000999764 | uncertain significance | Charcot-Marie-Tooth disease | 2019-08-14 | no assertion criteria provided | research |